Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer's disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday
Some of the more commonly identified risk factors are below (Reinking, 2018)
The highest OD in experimental media supplemented with selenium was achieved by C
Number of Sessions Required: Some patients need one session for mild concerns, while others may require multiple sessions for optimal results
The group of wild-type mice treated with hepsin and a reduced dose of 200 mg/kg NAC exhibited significantly lower levels of both enzymes, indicating reduced liver damage compared to the other groups (Fig
PBMCs from healthy donors were differentiated with GM-CSF (2050 ng/mL) for 6 days, followed by polarization with LPS (100 ng/mL) and IFN- (2050 ng/mL) for 12 days
US$ 23.94
:max_bytes(150000):strip_icc()/GettyImages-2169095535-f8d8276415dd4300a867a1f8b7de098f.jpg)
US$ 22.57
US$ 28.10
US$ 20.54
